StreetAlpha.app
Home › Stocks › QNTM

Quantum Biopharma Ltd. (QNTM)

$1.29
▼ −9.15%
LAST CLOSE · NOV 20

Quantum BioPharma develops drug candidates for neurodegenerative, inflammatory, metabolic and alcohol misuse disorders. It last closed at $1.29 on Nov 20, down 9.15% on the day.

AI Auto Pilots
Is QNTM in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold QNTM.

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on QNTM
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on QNTM

Technical Analysis

QNTM · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 53% below its 20 day and 110% below its 50 day average. It is 180% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the 52 week low at $1.26, and the nearest resistance the Pivot at $1.32.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 16.0%/day
Key levels
$12.4252 week high+862.8%
$3.61200 day average+179.8%
$2.97100 day average+130.2%
$2.7150 day average+110.1%
$2.31Swing high (Nov 9)+79.1%
$1.9720 day average+52.7%
$1.38Pivot R1+7.0%
$1.32Pivot+2.3%
$1.29Last close
$1.2652 week low−2.3%
$1.23Pivot S1−4.7%
Indicators
RSI (14)22.21Oversold below 30Oversold
MACD-0.35Below its signal lineBearish
Stochastic9.2Near the bottom of its rangeOversold
ADX (14)41.9Strong downtrend
Williams %R-97.2Oversold below −80, overbought above −20Oversold
CCI (20)-145.2Oversold below −100, overbought above 100Oversold
Rate of change−38.7%Change over 10 sessionsBearish
ATR (14)$0.21Typical daily range, 16.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for QNTM

What happened before

See how QNTM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow QNTM usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How QNTM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for QNTMHow many large options trades hit QNTM, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

QNTM Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲14 buying vs 5 selling
  • ▲Shares held by funds +28.9%
  • ▲Funds holding +2
  • ●No superinvestor moves
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding2927+7.4%
In funds' top 1000–
Held by funds–––
New / increased5 / 93 / 8+27.3%
Reduced / sold out1 / 44 / 3−28.6%
Put/call ratio–––
SuperinvestorsKen GriffinHolding
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See QNTM institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether QNTM is in one of them and how their past QNTM trades turned out.

QNTM in the AI portfolios
Loading…

QNTM News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered QNTM in an article yet. Here's the latest on the wider market.

QNTM in the news

About Quantum Biopharma

Quantum BioPharma is a biopharmaceutical company based in Toronto that develops drug candidates for neurodegenerative, inflammatory, and metabolic disorders, as well as alcohol misuse. Its lead candidate, Lucid-MS, is being researched as a possible treatment for multiple sclerosis and is at the preclinical stage. The company has also licensed unbuzzd, a dietary supplement drink intended for people who have consumed excess alcohol, to Unbuzzd and Celly U.S. for retail sale. It is also developing a healthcare product for use in hospitals and emergency departments.

Headquarters
Toronto